Nacuity Pharmaceuticals, Inc.
Clinical trials sponsored by Nacuity Pharmaceuticals, Inc., explained in plain language.
-
New cystinosis drug shows promise in early trial
Disease control OngoingThis study tests a new oral solution called NPI-001 in people with cystinosis, a rare disease that causes cystine buildup in cells. Researchers want to see if NPI-001 is safe and works better than the current drug cysteamine. About 12 participants aged 10 and older will stop thei…
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Eye implant may delay cataracts after vitrectomy
Disease control OngoingThis study tests a special implant placed in the eye during vitrectomy surgery to see if it can safely slow down cataract formation. About 30 adults who need vitrectomy and already have some cataract will receive the implant. The goal is to delay cataract progression, possibly re…
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC